Top States
Nira+ Top StatesAug 2026
Top states where Nira+ is active based on indexed sales coverage.
Is this your Brand? Log in to Hoodie!
Aug 2026
We develop high-quality, THC and CBD-rich products aimed at improving the quality of life for cannabis patients. With deep roots in science and medicine, we are focused on purity and consistency. Our products offer patients new options for improved wellness.
NIRA+ achieved remarkable sales growth of 91.7% YoY, elevating its rank from #6 to #2 in Virginia. Despite a 15.6% decline over the last three months, the brand's premium positioning remains strong, with a 4.1% uptick in sales recently.
Categories
Top States
Top states where Nira+ is active based on indexed sales coverage.
Trend View
24-Month Trend

Average Price
$38.56
YoY Sales Trend
59.5%
2Y Sales Trend
186.3%
Concentrates dominate at 67.0% of total sales, surging +201.3% YoY—fastest in the market. Oral products hold 28.3% with +2.5% YoY growth, while Topicals account for 4.3%, climbing +89.9% YoY.
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Oral | 29.0% | $42.09 | 30.1% |
Unlock The Full Table
Log in to unlock the full category breakout table and image export actions for this brand.
Trend View
24-Month Trend

Average Price
$38.56
YoY Sales Trend
59.5%
2Y Sales Trend
186.3%
Category Breakout
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Concentrates | 66.8% | $38.41 | 246.1% |
| Oral | 29.0% | $42.09 | 30.1% |
| Topicals | 4.2% | $25.31 | 118.5% |
State Rank Table
| State | Concentrates | Oral | Topicals |
|---|---|---|---|
| Virginia | 4 | 2 | 2 |
| Pennsylvania | 22 | 12 | ⊖ |
NIRA+ has a stronghold in Virginia and Pennsylvania, with Virginia representing 77.2% of its sales. Currently active in 2 states, the brand benefits from significant geographic concentration.
| State | Concentrates | Oral | Topicals |
|---|---|---|---|
| 22 | 12 | ⊖ |
Unlock The Full Table
Log in to unlock the full state rank table and compare every category row for this brand.
Market Position
NIRA+ ranks #2 in the Concentrates category, competing closely with THE LAB at #1 and AMBER at #3. Over the past year, it improved its position from #6 to #2, gaining ground on its competitors.
SKU View
Top products for Aug 2026 with sales and momentum indicators.
| Product | Category | MoM |
|---|---|---|
#2 | Concentrates | 158.5% |
#4 | Concentrates | 92.6% |
#6 | Concentrates | 20.5% |
#8 | Oral | 8.9% |
Unlock The Full Table
Log in to unlock the full top selling products table and export the share image for this section.
Benchmarking
Peer brands benchmarked against Nira+ using competitive landscape rank coverage, proximity, and momentum.